Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-22

Clinical Trial Update: Pharmacogenetics of Doxazosin for Cocaine Dependence [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on pharmacogenetics of doxazosin for cocaine dependence completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxazosin (doxazosin)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Cocaine Dependence | Phase 2 | Status: COMPLETED | Results posted: 2019-07-22